6533b858fe1ef96bd12b6bcf
RESEARCH PRODUCT
Growth hormone protects human lymphocytes from irradiation-induced cell death
L. CrostaMaria D'alcamoRenato BernardiniGiovanna M. ScotoLiborio RampelloGiuseppina CantarellaDaria BrambillaTullio PalmucciVincent GoffinLaurence Lempereursubject
Pharmacologymedicine.medical_specialtyProgrammed cell deathmedicine.diagnostic_testCellCancerGrowth hormone receptorBiologymedicine.diseaseHaematopoiesisEndocrinologymedicine.anatomical_structureImmune systemWestern blotApoptosisInternal medicinemedicineCancer researchhormones hormone substitutes and hormone antagonistsdescription
1. Undesired effects of cancer radiotherapy mainly affect the hematopoietic system. Growth hormone (GH) participates in both hematopoiesis and modulation of the immune response. We report both r-hGH cell death prevention and restoration of secretory capacities of irradiated human peripheral blood lymphocytes (PBL) in vitro. 2. r-hGH induced cell survival and increased proliferation of irradiated cells. Western blot analysis indicated that these effects of GH were paralleled by increased expression of the antiapoptotic protein Bcl-2. 3. r-hGH restored mitogen-stimulated release of IL-2 by PBL. Preincubation of irradiated lymphocytes with the growth hormone receptor (GHR) antagonists B2036 and G120 K abrogated r-hGH-dependent IL-2 release. 4. These results demonstrate that r-hGH protects irradiated PBL from death in a specific, receptor-mediated manner. Such effect of r-hGH on PBL involves activation of the antiapoptotic gene bcl-2 and prevention of cell death, associated with preserved functional cell capacity. Finally, potential use of GH as an immunopotentiating agent could be envisioned during radiation therapy of cancer.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2003-04-01 | British Journal of Pharmacology |